Add BrightSurf on Google Email

Science News Archive 2005 - Page 54


Page 54 of 165

Nitric oxide could extend fertility

Researchers found that exposing egg cells to nitric oxide can slow the hardening of their outer shells and increase the release of cortical granules, potentially extending their fertilizable time window. This could lead to improved fertility in women and reduce the risk of chromosomal abnormalities during early embryonic development.

SourceAmerican Chemical Society·JournalBiochemistry·DateSep 7, 2005

The right drug at the right time

A team of scientists has created a new method for controlled release of drugs by layering thin polymer films with embedded drugs. This technique allows for precise timing and sequence control, opening up broader applications in medicine.

Method slashes quantum dot costs by 80 percent

Researchers at Rice University have discovered a way to reduce the cost of producing quantum dots by 80% by replacing expensive solvents with cheap heat-transfer fluids. The new method uses mathematical modeling and experimentation to predict particle size and growth behavior based on solvent properties.

SourceRice University·JournalNanotechnology·DateSep 7, 2005

The shadow over consumers

Researchers found that consumers tend to spend more money on brand-name items when someone they don't know is nearby. In contrast, consumers are more likely to buy cheaper items when no one is around. The study suggests that store owners can increase profits by optimizing product placement to minimize feelings of isolation or anxiety.

SourceUniversity of Alberta·JournalJournal of Consumer Research·DateSep 7, 2005

Key regulator of blood glucose levels discovered

Researchers at the Salk Institute have identified a new target for diabetes treatment: the protein TORC2. TORC2 regulates glucose production in liver cells and its activation can improve insulin sensitivity. The discovery holds promise for developing more effective diabetes medications.

SourceSalk Institute·JournalNature·DateSep 7, 2005

Academy and Tekes launch new funding programme

The Academy of Finland and Tekes have launched a new funding programme to strengthen key areas of science and technology in Finland. The programme aims to build longer-term international research cooperation by hiring top foreign researchers, who will work as part of the Finnish research community.

Results of the ELISA II trial

The ELISA II trial found that triple antiplatelet (AP) therapy reduced enzymatic infarct size and improved epicardial coronary artery flow in patients with non-ST segment elevation acute coronary syndrome (NSTE ACS). Triple AP therapy also showed a trend towards better event-free survival at 96 hours and 30 days after randomization.

Displaced songbirds navigate in the high Arctic

Researchers found that displaced songbirds in the high Arctic use a combination of geomagnetic and solar cues to adjust their orientation. The study suggests that birds may rely on declination to determine longitudinal position, allowing them to navigate despite challenging conditions.

SourceCell Press·JournalCurrent Biology·DateSep 6, 2005

Recent improvements in prostate cancer outcomes may be result of shift in classification

A study found that nearly 60% of prostate cancer specimens received higher Gleason scores than original assignments, suggesting that pathologists are more likely to assign high scores to contemporary tumor samples. This 'Will Rogers phenomenon' may lead to a false sense of therapeutic accomplishment and skew mortality rates.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateSep 6, 2005